Since the interference efficacies of imperatorin and P2X4 shRNA treatment were similar, the mechanism of action for imperatorin in protecting against obesity-induced cardiac sympathetic neuropathic injury should be closely related to the downregulation of P2X4 receptors on satellite glial cells. The gene discussed is P2RX4; the disease is obesity disorder.